Response Genetics, Inc
RGDXQ · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 7.9% | -15.6% | 5.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 21.9% | 40.1% | 47.2% | 44.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -109% | -77.8% | -40.1% | -38.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -111.9% | -81% | -37.8% | -39.3% |
| EPS Diluted | -0.52 | -0.35 | -0.22 | -0.28 |
| % Growth | -48.6% | -59.1% | 21.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |